Co-Morbidity and Self Medication in Schizophrenia: Involvement of Endogenous Morphine Signaling Mechanisms

E-ISSN： 1873-5592|13|11|1454-1457

ISSN： 1389-4501

Source： Current Drug Targets, Vol.13, Iss.11, 2012-10, pp. : 1454-1457

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanisms of Involvement of Eicosanoids and their Precursors in the Pathophysiology and Treatment of Schizophrenia

Medicinal Chemistry, Vol. 9, Iss. 6, 2013-09 ,pp. : 763-773

Bentham Science Publishers

Access to resources Recommend Favorite

Co-morbidity Across Levels of Hospital Security

By Beck Alison Hunt Timothy

Addiction Research and Theory, Vol. 10, Iss. 4, 2002-01 ,pp. : 387-398

Informa Healthcare

Access to resources Recommend Favorite

Co-morbidity of drug addiction: An analysis of epidemiological data and possible etiological models

By Demetrovics Zsolt

Addiction Research and Theory, Vol. 17, Iss. 4, 2009-08 ,pp. : 420-431

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of Cardioprotective `Conditioning' Strategies in Aging and Diabetic Cohorts: The Co-Morbidity Conundrum

By Przyklenk Karin

Drugs & Aging, Vol. 28, Iss. 5, 2011-05 ,pp. : 331-343

Adis International

Access to resources Recommend Favorite

Poly-Pharmacy Among the Elderly: Analyzing the Co-Morbidity of Hypertension and Diabetes

Current Pharmaceutical Design, Vol. 21, Iss. 6, 2015-02 ,pp. : 791-805

Bentham Science Publishers

Access to resources Recommend Favorite